Riskpilot← Back to searchSign inGet full accessProstatype Genomics AB
ABActiveOrg 5567260285Augustendalsvägen 20Research and experimental development on natural sciences and engineering · NACE 7210Est. 20075-9 employees
Revenue 2024
SEK 199K
-85% vs 2023
EBITDA margin
-14135.7%
+9% vs 2023
Equity ratio
83.8%
Financial strength
Net profit 2024
SEK -41,1M
-19% vs 2023
| Revenue | SEK 199K | -85% |
| EBITDA | SEK -28,1M | +9% |
| Net profit | SEK -41,1M | -19% |
| Total assets | SEK 49,1M | -12% |
| Equity | SEK 41,2M | +32% |
| Employees | — | — |
Legal name
Prostatype Genomics AB
Org number
5567260285
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12 mars 2007
Share capital
SEK 670 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av Koch, Lars Anders Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget skall direkt eller indirekt bedriva forskning, utveckling och försäljning av medicintekniska produkter och läkemedel, äga och förvalta aktier och andra värdepapper, samt därmed förenlig verksamhet.
Address
Augustendalsvägen 20
Email
info@prostatypegenomics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 56 | 162 | 74 | 684 | 10 | 683 | 1 356 | 199 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −12 193 | −11 284 | −4 518 | −8 969 | −7 708 | −15 765 | −15 460 | −26 786 | −30 970 | −28 130 |
| Depreciation & amort. | −111 | −107 | −107 | −195 | −154 | −149 | −88 | −1 904 | −1 875 | −1 899 |
| EBIT | −12 304 | −11 391 | −4 625 | −9 164 | −7 862 | −15 914 | −15 548 | −28 690 | −32 845 | −30 029 |
| Net financials | −62 | −99 | −121 | −154 | −684 | −1 494 | −81 | −396 | −2 356 | −23 306 |
| Profit before tax | −12 366 | −11 490 | −4 747 | −9 318 | −8 546 | −17 408 | −15 630 | −29 087 | −34 559 | −41 051 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −12 366 | −11 490 | −4 747 | −9 318 | −8 546 | −17 408 | −15 630 | −29 087 | −34 559 | −41 051 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5 059 | 4 145 | 19 714 | 19 711 | 17 574 | 33 663 | 40 203 | 30 950 | 55 584 | 49 126 |
| Equity | 3 384 | −1 320 | 14 928 | 6 223 | 8 546 | 28 290 | 35 906 | 26 151 | 31 196 | 41 150 |
| Long-term debt | 151 | 3 862 | 2 026 | 9 550 | 6 452 | 1 067 | 867 | 467 | 67 | 0 |
| Short-term debt | 1 524 | 1 603 | 2 761 | 3 938 | 2 575 | 4 306 | 3 430 | 4 333 | 24 321 | 7 975 |
| Total debt | 1 675 | 5 465 | 4 787 | 13 488 | 9 027 | 5 373 | 4 297 | 4 800 | 24 388 | 7 975 |
EBITDA margin
-14135.7%
This company
15.8%
Market median
-89566% vs market
20152024
Equity ratio
83.8%
This company
38.2%
Market median
+119% vs market
20152024
Return on equity
-99.8%
This company
18.4%
Market median
-642% vs market
20152024
Net profit margin
-20628.6%
This company
8.1%
Market median
-254774% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via Bolagsverket / SCB · Period 2014-07-01 – 2015-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JK Chief Auditor | Chief Auditor | 2022 | — | — |
LA Chief Auditor | Chief Auditor | 2020 | — | — |
KF Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
LA External Signatory | External Signatory | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Prostatype Genomics AB (this company)
PROSTATYPE GENOMICS INCProstatype Genomics IncBoard members of Prostatype Genomics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Kjell Joakim Söderin | Chief Auditor | 0 companies |
| Lars Anders Meyer | Chief Auditor | 0 companies |
| Karl Fredrik Rickman | Chief Executive Officer | 0 companies |
| Lars Anders Koch | External Signatory | 0 companies |
| Anders Bo Folke Garibaldi Lundberg | Chairman | 0 companies |
| Bengt Håkan Englund | Board of Directors | 0 companies |
| Mattias Viktor Prage | Board of Directors | 0 companies |
| Per Henrik Nilsson | Board of Directors | 0 companies |
| Johan Fredrik Waldhe | Board of Directors | 0 companies |
| Christoph Petry | Board of Directors | 0 companies |
| Sven Anders Liljeblad | Chairman | 0 companies |
| Karlheinz Schmelig | Board of Directors | 0 companies |
| Chunde Li | Board of Directors | 0 companies |
| Carl Jörgen Dahlström | Board of Directors | 0 companies |
| Jan Michael Häggman | Board of Directors | 0 companies |